Skip to content

Laser at Lumbar Acupoint on Pain and Quality of Life in Chronic Pelvic Pain

CompletedNot applicableNCT05537207
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

To investigate the effect of low-level laser at lumbar sensitized acupoint on pain perception in chronic pelvic pain. BACKGROUND: chronic pelvic pain is one of the serious problems in the female, resulting in pain and less physical activity.

Study details

Official title
Effect of Laser at Lumbar Sensitized Acupoint on Pain Perception and Quality of Life in Female Chronic Pelvic Pain
Conditions
Interventions
  • Device: low level laser therapy
  • Other: non-steroidal drugs
Sponsor
October 6 University
Start date
2022-10-01
Primary completion
2022-12-15
Sex
Female
Age range
from 25 Years to 40 Years
Results posted
No results posted in this snapshot
Countries
Egypt
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Thirty six female with chronic pelvic pain * Their age ranged from 25 to 40 years old. * With the maximum parity number three. * Their body mass index (BMI) (20:29.9) kg/m2. * their pain score on the Visual Analog Scale (VAS) above 4 cm * Thirty-six married women diagnosed with chronic pelvic pain (CPP) * with a prior history of treatment for pelvic inflammatory disease (PID) * women with periodic lower abdominal or pelvic pain for at least six months and met -- the clinical diagnostic criteria for PID based on the presence of all three major criteria: lower abdominal tenderness, cervical motion tenderness, and bilateral adnexal tenderness * at least one minor supporting criterion: oral temperature \>38.3°C (101 °F), mucopurulent cervical discharge or cervical friability, abundant WBCs on saline microscopy of vaginal fluid, elevated ESR and/or CRP, or laboratory-confirmed cervical infection with N. gonorrhoeae or C. trachomatis Exclusion Criteria: * Any difficulty to communicate or understanding program instructions * any other conditions that caused pain (for example fibromyalgia and arthritis) * any psychiatric or cognitive symptoms * any other musculoskeletal disorders or neurologic diseases * any other conditions causing pelvic pain (e.g., fibromyalgia, arthritis), history of musculoskeletal or neurological diseases affecting the lower extremities and spine (such as lumbar disc herniation), acute pelvic inflammatory disease (PID), pregnancy or lactation, tumors, pelvic congestion, tuberculous PID, endometriosis, adenomyosis, gynecological tumors, or other gyneco-logical conditions that could contribute to chronic pelvic pain (CPP). * any issues at acupoint sites (such as ulcers or skin conditions); impairments in other systems that could lead to pelvic and lumbosacral pain (e.g., digestive, motor, or urinary issues) * severe systemic illnesses affecting the hematologic, digestive, urinary, or cardiovascular systems * mental illness; cognitive deterioration * immune-compromising diseases (such as diabetes or HIV/AIDS); and contraindications to NSAIDs

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05537207